Jason R. Gee

Urology
41 Mall Rd
Burlington, MA 01805

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Endovascular Downstaging: A New Method for Managing Renal Cell Carcinoma Tumor Thrombus Invading the Inferior Vena Cava Above the Hepatic Veins (Level III) or into the Heart (Level IV).

Endovascular Downstaging: A New Method for Managing Renal Cell Carcinoma Tumor Thrombus Invading the Inferior Vena Cava Above the Hepatic Veins (Level III) or into the Heart (Level IV).

Journal: Cancers
Published: December 18, 2024

MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype.

MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype.

Journal: Genes
Published: September 28, 2016

A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.

A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.

Journal: Cancer prevention research (Philadelphia, Pa.)
Published: June 22, 2016

Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy.

Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
Published: August 28, 2015

Underutilization of immediate intravesical chemotherapy following TURBT: results from NSQIP.

Underutilization of immediate intravesical chemotherapy following TURBT: results from NSQIP.

Journal: The Canadian journal of urology
Published: July 01, 2014

Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.

Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.

Journal: The Journal of urology
Published: April 10, 2014

Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancer.

Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancer.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: March 20, 2014

Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.

Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.

Journal: The Prostate
Published: August 17, 2012

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers.

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers.

Journal: European urology
Published: July 30, 2012

A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.

A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.

Journal: Cancer prevention research (Philadelphia, Pa.)
Published: February 02, 2012
Showing 1-10 of 10

Last Updated: 09/26/2026